Technology | December 14, 2015

Stratasys and Vital Images Partner on 3-D Printing

Partnership will enable streamlined access to 3-D printed models

An example of a 3-D printed aortic valve with calcified areas highlighted in blue that Vital exhibited as the types of on-demand 3-D printing that can be done with its new service.

December 14, 2015 — Vital Images Inc. announced a partnership with Stratasys Ltd., a 3-D printing and additive manufacturing company, to develop an industry first print-on-demand service using Vital’s Vitrea advanced visualization software and Stratasys’ 3-D printing services. 

The partnership was demonstrated with printed 3-D models featuring both company’s technology at both Stratasys’ and Vital’s booths at the 2015 Radiological Society of North America (RSNA) annual meeting.

“The advantage of offering this print-on-demand service to Vital’s global hospital and imaging center customers is that they can have best-of-breed technology available at their fingertips without first acquiring a 3-D printer,” said Jim Litterer, president and CEO at Vital. “In addition, they can have these capabilities using the software they are already accustomed to using in their daily practice.”

“We understand the importance of streamlining the use of 3-D printing in the clinical setting,” said Scott Rader, general manager, medical solutions at Stratasys. “Partnering with Vital to integrate our 3D printing capabilities leverages the strengths of the two companies, with the mutual goal of improving patient care and providing clinicians with the tools they need, when they need them.”

At RSNA, Vital showcased a Stratasys Objet260 Connex3 3-D Printer, which supports simultaneous multi-material, multi-color 3-D prints to mimic both the appearance and texture of patient anatomy. Vital’s Vitrea software takes patient scans and converts them into STL files for direct use with a 3-D printer. A range of anatomical models from actual patient studies, printed with the Objet260 Connex3, will be on display as well.

For more information: www.vitalimages.com, www.stratasys.com

Related Content

Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | September 11, 2017
September 11, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has sele
LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

LAA closure during open heart surgery in the LAACS Study showed better outcomes for all patients.

Feature | Left Atrial Appendage (LAA) Occluders| September 07, 2017
September 7, 2017 — Closure of the left atrial appendage (LAA) during heart surgery protects the brain, according to
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices| September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
Minneapolis Heart Institute Foundation Enrolls First Patient in TRILUMINATE Tricuspid Repair Trial
News | Heart Valve Technology| September 05, 2017
Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a clinical study to...
Abbott Initiates U.S. Pivotal Study of Amplatzer Device for Patent Ductus Arteriosus
News | Congenital Heart| September 05, 2017
Abbott announced it has initiated a U.S. pivotal clinical study evaluating the safety and effectiveness of a modified...
World's First Successful 52-mm Transcatheter Tricuspid Valve Implantation Completed in Italy
News | Heart Valve Technology| August 31, 2017
NaviGate Cardiac Structures Inc. (NCSI) announced that its Gate catheter-guided tricuspid atrioventricular valved stent...
Sponsored Content | Videos | Heart Valve Technology| August 30, 2017
Azeem Latib, M.D., MBBCh, FCP, interventional cardiologist at Columbus Hospital in Milan, Italy, discusses the latest
Overlay Init